IRIS
VITA, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 30.395
NA - Nord America 29.290
AS - Asia 16.491
SA - Sud America 6.126
Continente sconosciuto - Info sul continente non disponibili 996
AF - Africa 462
OC - Oceania 24
AN - Antartide 1
Totale 83.785
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.628
RU - Federazione Russa 14.965
SG - Singapore 7.227
BR - Brasile 5.242
CN - Cina 4.686
IE - Irlanda 3.933
SE - Svezia 2.903
IT - Italia 1.804
HK - Hong Kong 1.616
DE - Germania 1.544
UA - Ucraina 1.243
FR - Francia 1.065
VN - Vietnam 946
FI - Finlandia 885
PL - Polonia 832
GB - Regno Unito 583
IN - India 527
AR - Argentina 293
CA - Canada 268
BD - Bangladesh 260
MX - Messico 188
TR - Turchia 169
EC - Ecuador 164
IQ - Iraq 149
ZA - Sudafrica 123
CO - Colombia 117
BE - Belgio 116
ID - Indonesia 110
PK - Pakistan 104
NL - Olanda 101
AT - Austria 99
VE - Venezuela 97
MA - Marocco 93
UZ - Uzbekistan 90
ES - Italia 77
JP - Giappone 76
CI - Costa d'Avorio 58
CL - Cile 58
PY - Paraguay 54
AZ - Azerbaigian 46
PE - Perù 46
KE - Kenya 44
CZ - Repubblica Ceca 42
TN - Tunisia 40
LT - Lituania 38
SA - Arabia Saudita 38
NP - Nepal 36
IR - Iran 35
PH - Filippine 35
AE - Emirati Arabi Uniti 33
JO - Giordania 33
CR - Costa Rica 32
KZ - Kazakistan 31
IL - Israele 30
MY - Malesia 30
JM - Giamaica 28
UY - Uruguay 28
EG - Egitto 27
DO - Repubblica Dominicana 26
HN - Honduras 26
BO - Bolivia 23
KG - Kirghizistan 23
AL - Albania 22
DZ - Algeria 22
OM - Oman 22
EU - Europa 20
TH - Thailandia 20
RS - Serbia 19
CH - Svizzera 18
LB - Libano 18
NI - Nicaragua 17
RO - Romania 17
PA - Panama 16
AU - Australia 15
PS - Palestinian Territory 15
GT - Guatemala 13
KR - Corea 11
PT - Portogallo 11
KW - Kuwait 10
SK - Slovacchia (Repubblica Slovacca) 10
SN - Senegal 10
TT - Trinidad e Tobago 10
GE - Georgia 9
PR - Porto Rico 9
AO - Angola 7
BA - Bosnia-Erzegovina 7
DK - Danimarca 7
ET - Etiopia 7
GA - Gabon 7
HU - Ungheria 7
LK - Sri Lanka 7
MD - Moldavia 7
NZ - Nuova Zelanda 7
QA - Qatar 7
SV - El Salvador 7
SY - Repubblica araba siriana 7
BY - Bielorussia 6
GR - Grecia 6
MN - Mongolia 6
NO - Norvegia 6
Totale 82.705
Salva come PNG Salva come JPEG
Città #
Moscow 4.726
Dublin 3.927
Singapore 3.430
Ashburn 3.402
Dallas 3.070
Chandler 2.700
Jacksonville 2.565
Nyköping 1.764
Beijing 1.687
Hong Kong 1.599
San Jose 1.118
Council Bluffs 1.105
The Dalles 896
Warsaw 806
Princeton 740
Medford 642
Lauterbourg 632
Cambridge 622
Los Angeles 593
Des Moines 511
Dearborn 487
Ann Arbor 480
Munich 401
Messina 383
São Paulo 382
New York 342
Ho Chi Minh City 333
Buffalo 332
Boardman 299
Tianjin 211
Wilmington 203
Hanoi 185
San Mateo 173
Shenyang 172
Rio de Janeiro 168
Jinan 167
Guangzhou 155
Orem 151
Woodbridge 148
Turku 145
Santa Clara 144
Redondo Beach 134
Hyderabad 131
Belo Horizonte 128
Bremen 126
Frankfurt am Main 126
Helsinki 124
Nanjing 122
Lancaster 115
Houston 112
Atlanta 109
Rome 104
Pune 103
Brussels 101
Hebei 94
Brasília 91
Curitiba 91
Seattle 89
Ningbo 86
Shanghai 86
Brooklyn 83
Zhengzhou 82
Chennai 81
Milan 80
Tashkent 79
Hangzhou 73
Porto Alegre 72
Chicago 70
Taizhou 70
Tokyo 70
Montreal 68
Baghdad 65
Haikou 65
Phoenix 64
San Francisco 64
London 63
Campinas 61
Columbus 61
Vienna 61
Guayaquil 60
Toronto 59
Abidjan 58
Denver 58
Johannesburg 54
Nuremberg 52
Quito 52
Guarulhos 51
Dong Ket 49
Shenzhen 48
Ribeirão Preto 47
Salvador 47
Baku 46
Stockholm 46
Norwalk 45
Poplar 44
Dhaka 43
Mexico City 43
Amsterdam 42
Mumbai 42
Boston 41
Totale 46.427
Salva come PNG Salva come JPEG
Nome #
Myopathy as the persistently isolated symptomatology of primary autoimmune hypothyroidism 684
A NOVEL SERUM MICRORNA SIGNATURE TO SCREEN TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY 369
HATTR italian registry: preliminary data from the collaborative network of telethon GUP 15010 study 342
6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR) 336
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol 332
A COMPUTER-ASSISTED AUTOMATIC METHOD FOR MYELINATED NERVE-FIBER MORPHOMETRY 299
A checklist for clinical trials in rare disease: Obstacles and anticipatory actions-lessons learned from the FOR-DMD trial 292
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 288
90th ENMC International Workshop: European Spinal Muscular Atrophy Randomised Trial (EuroSMART) 9-10 February 2001, Naarden, The Netherlands 281
A histochemical study of fibre types in rat extraocular muscles 259
Psychosocial impact of presymptomatic genetic testing for amyloidotic polyneuropathy 259
Responsiveness of clinical outcome measures in Charcot-Marie-Tooth disease 256
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 256
Clinical and pathological features of focal myositis 251
A CMT1A PATIENT WITH PAINFUL AND DISABLING SYMPTOMS: FAST RECOVERY AFTER IVIG TREATMENT. 251
24-Holter ECG in type II and III SMA 251
A new management of syncope: prospective systematic guideline-based evaluation of patients referred urgently to general hospitals 251
Integrated care of muscular dystrophies in Italy. Part 1. Pharmacological treatment and rehabilitative interventions 245
Agenesis of the Internal Carotid Artery Associated with Generalized Epilepsy 242
Integrated care of muscular dystrophies in Italy. Part 2. Psychological treatments, social and welfare support, and financial costs 241
A Nouvel serum MicroRNA signature to screen ATTR 233
Behaviour of vinculin and talin in perineurial cells in healthy subjects and in subjects affected by diabteic neuropathy 231
Adolescenti e infezioni sessualmente trasmesse: conoscenze e comportamenti. 230
A 5-center experience with intrathecal administration of nusinersen in SMA1 in Italy letter to the editor of european journal of pediatric neurology regarding the manuscript “single-center experience with intrathecal administration of nusinersen in children with spinal muscular atrophy type 1” written by pechmann and colleagues” 228
Analisi dello stato di metilazione del promoter di O6-methylguanine DNA methyltransferase (MGMT) e TMS1/ASC nei gliomi cerebrali diffusi di basso grado: possibili implicazioni cliniche e prognostiche. 220
Ataluren in patients with nonsense mutation Duchenne muscular dystrophy (ACT DMD): A multicentre, randomised, double-blind, placebo-controlled, phase 3 trial 219
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 218
Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: a randomised, double-blind, placebo-controlled phase 2 trial 217
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area 216
A cytochemical study of apoptosis in metabolic myopathies 214
A family with autosomal dominant mutilating neuropathy not linked to either Charcot-Marie-Tooth disease type 2B (CMT2B) or hereditary sensory neuropathy type I (HSN I) loci 213
24 month longitudinal data in ambulant boys with Duchenne muscular dystrophy. 211
BILATERAL PARAMEDIAN THALAMIC INFARCT AFTER OCCLUSION OF THE ARTERY OF PERCHERON. 210
Disturbi acuti della visione 207
Awareness and behavioural and psychological symptoms of dementia (BPSD) impact in Alzheimer's disease 207
A life threatening case of β-enolase deficiency 205
A CLSM study of dystrophin associated proteins and some extra-cellular matrix components in human skeletal muscle 204
A comparative analysis of somatic and autonomic neuropathy in chronic alcoholics. 201
Health-related quality of life and functional changes in DMD: A 12-month longitudinal cohort study 201
Which are the factors influencing NIV adaptation and tolerance in ALS patients? 201
Dolori muscolari, deficit di forza e/o disturbi sensitivi 200
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 200
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 198
Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice 197
Alexithymia, burden and resilience in ALS’ caregivers 197
A decreased muscle content of HPRG correlates with the reduction of AMP deaminase activity observed in patients affected by myoadenylate deficiencies 196
alpha7/beta1 integrin distribution in correlation with talin-vinculin system 196
Expanded access program with Nusinersen in SMA type I in Italy: Strengths and pitfalls of a successful experience 194
Onset of hypothyroidism with polymyositis-like clinical features in elderly patients 193
Hippo signaling pathway is altered in Duchenne muscular dystrophy 192
Effect of exercise on telomere length and telomere proteins expression in mdx mice 192
Vacuolated PAS-positive lymphocytes on blood smear: An easy screening tool and a possible biomarker for monitoring therapeutic responses in Late Onset Pompe Disease (LOPD) 192
Nusinersen versus sham control in later-onset spinal muscular atrophy 192
Autonomic nervous system involvement in spinal muscular atrophy. 191
ATTRv amyloidosis Italian Registry: clinical and epidemiological data 191
NLRP3 inflammasome CSF expression and neuropsychological changes in idiopathic normal pressure hydrocephalus 189
Alterazioni neuropsicologiche in emodializzati: confronto tra adulti e anziani 188
Characterization and functional analysis of the human microRNA 363 in glioblastoma transfected cell lines 186
Analisi dello stato di metilazione del promoter di O6-methylguanine DNA methyltransferase (MGMT) e TMS1/ASC: possibili implicazioni cliniche e prognostiche nei gliomi cerebrali diffusi di basso grado 185
[Neuromuscular block induced by fazadinium. Electrophysiological study on fast and slow muscles in the rabbit]. 185
Emergenze respiratorie nelle malattie neurologiche 185
Clinical and genotypic of narcoleptic from North eastern Sicily: our sleep centre experience 184
Parenteral nutrition improves nutritional status, autonomic symptoms and quality of life in transthyretin amyloid polyneuropathy 184
An observational study of functional abilities in infants, children, and adults with type 1 SMA 184
Bezafibrate-induced myopathy: no evidence for defects in muscle metabolism. 182
A benign case of congenital myotonic dystrophy 182
Sleep and sleep‐modifying factors in chronic migraine patients during the COVID‐19 lockdown 181
Expression of the tumor necrosis factor receptor-associated factors I and 2 and regulation of the nuclear factor-kappa B antiapoptotic activity in human gliomas 181
Central and peripheral autonomic failure in cold induced sweating syndrome type 1 180
Fahr's syndrome: local inflammatory factors in the pathogenesis of calcification 179
Intrathecal administration of Nusinersen in type 1 SMA: successful psychological program in a single Italian center 179
Myasthenia Gravis: Unusual Presentations and Diagnostic Pitfalls 178
ANT1 expression and RAGE-NF-kB pathway activation in sporadic inclusion-body myositis 177
Bilateral paramedian thalamic infarct after occlusion of the artery of Percheron 175
Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 175
Pilot study of flavocoxid in ambulant DMD patients. 174
Charcot-Marie-Tooth 2F: phenotypic presentation of the Arg136Leu HSP27 mutation in a multigenerational family 173
Cardiac longitudinal and radial strain is impaired in TTR-FAP: a magnetic resonance and 2-dimensional strain echocardiography study. 172
Adult-onset centronuclear myopathy: evidence against a neurogenic pathology. 171
Cardiovascular autonomic control in Becker muscular dystrophy 171
A quantitative analysis of fibers in the controlateral sciatic nerves of the rabbit 171
Pilot study of serial casting in muscular dystrophy patients. 171
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies 171
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study 171
Apoptosis and apoptosis-related proteins in thyroid myopathies 170
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis. 170
Analisi comparativa della patologia vegetativa autonomica in emodializzati giovani e anziani 170
A novel Cx32 mutation with unusual phenotype. 170
Cardiac 99mTc-DPD uptake in subjects with Glu89Gln transthyretin gene mutation: is it the earliest sign of disease development? 170
Is overwork weakness relevant in Charcot-Marie-Tooth disease? 170
Espressione differenziale di un panel di miRNA in tumori cerebrali astrogliali con diverso grado di malignità. 169
Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene 168
Activation of nuclear factor-kappa B in inflammatory myopathies and Duchenne muscular dystrophy 168
Pilot study of serial casting of ankles in muscular dystrophy patients. 168
Neuropsychological patter in centronuclear myopathy due to DNM2 gene mutations. 168
AUDITORY SYSTEM INVOLVEMENT IN LATE ONSET POMPE DISEASE: A STUDY OF 20 ITALIAN PATIENTS 168
Modulation of neural nitric oxide synthase by the isoflavone genistein promotes muscle regeneration in mdx mice 167
Autoimmune juvenile limb-girdle myasthenia 166
Alterazioni neuro psicologiche in emodializzati: confronto tra adulti e anziani 165
Parenteral nutrition improves nutritional status, autonomic symptoms and qol in patients with TTR-FAP 164
Totale 21.067
Salva come PNG Salva come JPEG
Categoria #
all - tutte 286.342
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 286.342
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224.164 0 582 55 201 275 35 324 199 94 323 521 1.555
2022/202310.860 931 917 491 761 888 1.013 123 607 4.721 40 281 87
2023/20242.590 215 393 195 198 223 545 72 161 29 196 49 314
2024/202513.121 200 135 212 743 549 361 300 2.888 3.298 713 1.383 2.339
2025/202636.666 1.612 2.763 3.084 2.833 2.820 7.992 4.485 4.203 4.249 1.443 650 532
2026/20273.730 1.117 2.613 0 0 0 0 0 0 0 0 0 0
Totale 83.785